Successive Stability Indicating Spectrophotometric Technique for Simultaneous Determination of Quetiapine Fumarate and its Three Major Related Compounds

Author(s): Christine M. El-Maraghy*, Ekram H. Mohamed

Journal Name: Current Analytical Chemistry

Volume 16 , Issue 4 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Quetiapine Fumarate (QTF) is an atypical antipsychotic drug used to treat mental disorders as depression and schizophrenia. The analysis of the dug in the presence of its precursors, degradants and impurities without interference represents a challenge for the analysts. The regulatory requirements recommended by ICH stated that the impurities above or equal to 0.1% must be identified, characterized and determined. The aim of this work was to introduce three smart and selective spectrophotometric methods that could resolve the complete overlapping of QTF drug with its three related compounds; namely lactam (LAC), N-oxide (OXD) and des-ethanol (DES) without prior separation or extraction step.

Methods: So far there is no spectrophotometric method reported in the literature for the analysis of QTF drug with its three related compounds without interference. The First derivative zero crossing (1D-ZC), Spectrum subtraction (SS), and Simultaneous derivative ratio (S1DD) are well-developed methods used for determination and resolution of multicomponent mixtures. While Ratio difference isosbestic point method is a new method that needs two isoabsorptive points for its application and was successfully adopted for simultaneous estimation of ternary mixtures.

Results: The linearity range was found in the range of (6-50 μg/mL) for Quetiapine fumarate, (6-110 μg/mL) for lactam, (4-28 μg/mL) for N-oxide and (6-32 μg/mL) for Des-ethanol. The method validation was performed according to ICH guidelines. The results were statistically compared with a reported HPLC method and no significant difference was obtained.

Conclusion: The presented spectrophotometric technique highlighted the significance of different tools such as normalized spectra and isoabsorptive points, especially when combined together for the determination and resolution of complex quaternary mixtures as that of QTF and its three major impurities. The proposed methods were smart, accurate and sensitive and were able to determine the four components showing sever overlap without prior separation. The proposed methods are rapid, cheap ecofriendly (green method) and didn’t require any sophisticated programs and could be easily adopted for the routine determination of complex multicomponent mixtures with minimum sample preparation.

Keywords: First derivative zero crossing, quetiapine, ratio difference isosbestic point, related compounds, schizophrenia, spectrum subtraction.

[1]
Cheer, S.M.; Wagstaff, A.J. Quetiapine. A review of its use in the management of schizophrenia. CNS Drugs, 2004, 18(3), 173-199.
[http://dx.doi.org/10.2165/00023210-200418030-00004] [PMID: 14871161]
[2]
ICH, Guideline Q3A (R). Impurities in New Drug Substances; ICH Secretariat: Geneva, 2002.
[3]
Belal, F.; Elbrashy, A.; Eid, M.; Nasr, J.J. Stability-indicating HPLC method for the determination of Quetiapine: Application to tablets and human plasma. J. Liq. Chromatogr. Relat. Technol., 2008, 31(9), 1283-1298.
[http://dx.doi.org/10.1080/10826070802019681]
[4]
Bharathi, Ch.; Prabahar, K.J.; Prasad, ChS.; Srinivasa Rao, M.; Trinadhachary, G.N.; Handa, V.K.; Dandala, R.; Naidu, A. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate. Pharmazie, 2008, 63(1), 14-19.
[PMID: 18271296]
[5]
Korrapolu, S.; Bollineni, S.; Nalluri, B.N. Stability indicating RP-HPLC-PDA method for the estimation of Quetiapine fumarate in bulk and pharmaceutical dosage forms. J. Chem. Pharm. Res., 2012, 4(8), 3877-3884.
[6]
Krishna, S.R.; Rao, B.M.; Rao, N.S. A validated stability indicating HPLC method for the determination of related substances in Quetiapine fumarate. Rasayan J. Chem., 2008, 1(3), 466-474.
[7]
Kumar, R.N.; Rao, G.N.; Naidu, P.Y. Stability indicating fast LC method for determination of Quetiapine fumarate related substances in bulk and pharmaceutical formulation. Pharm Lett, 2011, 3(3), 457-469.
[8]
Raju, I.V.S.; Raghuram, P.; Sriramulu, J. Development and validation of a new analytical method for the determination of related components in Quetiapine hemifumarate. Chromatographia, 2009, 70, 545-550.
[http://dx.doi.org/10.1365/s10337-009-1183-z]
[9]
Rosa, P.C.P.; Pires, I.F.R.; Markman, B.E.O.; Perazzo, F.F. Development and validation of RP-HPLC method for the determination of related compounds in Quetiapine hemifumarate raw material and tablets. J. Anim. Plant Sci., 2013, 3(8), 6-15.
[10]
Stolarczyk, E.U.; Groman, A.; Kaczmarek, L.S.; Gołebiewski, P. GC method for quantitative determination of residual 2-(2-chloroethoxy) ethanol (CEE) and N-methyl-2-pyrrolidinone (NMP) in quetiapine. Acta Pol. Pharm., 2007, 64(2), 187-189.
[PMID: 17665871]
[11]
Mahadik, M.V.; Patre, N.G.; Dhaneshwar, S.R. Stability-indicating HPTLC method for quantitation of Quetiapine fumarate in the pharmaceutical dosage form. Acta Chromatogr., 2009, 21(1), 83-93.
[http://dx.doi.org/10.1556/AChrom.21.2009.1.7]
[12]
Salem, H.; Amer, S.M.; Maraghy, C.M.E.; Nebsen, M. Validated HPLC and thin layer-densitometric methods for determination of quetiapine fumarate in presence of its related compounds. J. Chromatogr. Sep. Tech., 2015, 6(5), 2-7.
[13]
Trivedi, R.K.; Patel, M.C. Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form. Sci. Pharm., 2011, 79(1), 97-111.
[http://dx.doi.org/10.3797/scipharm.1009-12] [PMID: 21617775]
[14]
Bonazzi, D.; Gotti, R.; Andrisano, V.; Cavrini, V. Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC). J. Pharm. Biomed. Anal., 1997, 16(3), 431-438.
[http://dx.doi.org/10.1016/S0731-7085(97)00075-7] [PMID: 9589401]
[15]
Lotfy, H.M.; Hegazy, M.A.; Mowaka, S.; Mohamed, E.H. Validated spectrophotometric methods for simultaneous determination of Omeprazole, Tinidazole and Doxycycline in their ternary mixture. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2016, 153, 321-332.
[http://dx.doi.org/10.1016/j.saa.2015.07.106] [PMID: 26322842]
[16]
Lotfy, H.M.; Hegazy, M.A.; Mowaka, S.; Mohamed, E.H. Novel spectrophotometric methods for simultaneous determination of Amlodipine, Valsartan and Hydrochlorothiazide in their ternary mixture. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2015, 140, 495-508.
[http://dx.doi.org/10.1016/j.saa.2014.12.096] [PMID: 25638433]
[17]
Mohamed, E.H.; Lotfy, H.M.; Hegazy, M.A.; Mowaka, S. Different applications of isosbestic points, normalized spectra and dual wavelength as powerful tools for resolution of multicomponent mixtures with severely overlapping spectra. Chem. Cent. J., 2017, 11(1), 43.
[http://dx.doi.org/10.1186/s13065-017-0270-8] [PMID: 29086829]
[18]
Lamie, N.T.; Yehia, A.M. Development of normalized spectra manipulating spectrophotometric methods for simultaneous determination of Dimenhydrinate and Cinnarizine binary mixture. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2015, 150, 142-150.
[http://dx.doi.org/10.1016/j.saa.2015.05.048] [PMID: 26037499]
[19]
Mittapelli, V.; Vadali, L.; Devi, A.S.; Suryanarayana, M.V. Identification, isolation, synthesis and characterization of principal oxidation impurities in Quetiapine. Rasayan J. Chem., 2010, 3(4), 677-680.
[20]
Vessman, J.; Stefan, R.I.; Staden, J.F.V.; Danzer, K.; Lindner, W.; Burns, D.T.; Fajgelj, A.; Müller, H. Selectivity in analytical chemistry (IUPAC Recommendations 2001). Pure Appl. Chem., 2001, 73(8), 1381-1386.
[http://dx.doi.org/10.1351/pac200173081381]
[21]
Miller, J.N.; Miller, J.C. Statistics and Chemometrics for Analytical Chemistry; Pearson Education Limited: England, Harlow, 2005.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 4
Year: 2020
Page: [447 - 455]
Pages: 9
DOI: 10.2174/1573411014666180709145526
Price: $65

Article Metrics

PDF: 13
HTML: 1